Wolfgang Schoenfeld
President bij EUCODIS Bioscience GmbH Deutschland
Profiel
Wolfgang Schoenfeld is the founder of EUCODIS Bioscience GmbH, which was founded in 2004.
He held the title of Chief Executive Officer in 2009.
He is currently the Chairman-Management Board at EUCODIS Bioscience GmbH Deutschland, starting in 2004.
Dr. Schoenfeld has also held former positions as Director-Anti Infective Research at PLIVA dd, Principal at Bayer AG, Gérant at Mixis Genetics Ltd, and Faculty Member at Ruhr-Universität Bochum.
He obtained a doctorate degree from RWTH Aachen University.
Actieve functies van Wolfgang Schoenfeld
Bedrijven | Functie | Begin |
---|---|---|
EUCODIS Bioscience GmbH Deutschland
EUCODIS Bioscience GmbH Deutschland Miscellaneous Commercial ServicesCommercial Services EUCODIS GmbH researches and develops products for life science applications. It develops products for life science applications by utilizing vivo recombination and somatic hypermutation technology. The company focuses on development of products such as industrial enzymes, therapeutic proteins, agrochemicals, seed technologies, transgenic animals, biosynthetic pathways and human antibodies. The company was founded in 2004 and is headquartered in Vienna, Austria. | President | 01-01-2004 |
Eerdere bekende functies van Wolfgang Schoenfeld
Bedrijven | Functie | Einde |
---|---|---|
Ruhr-Universität Bochum | Corporate Officer/Principal | - |
BAYER AG | Corporate Officer/Principal | - |
Mixis Genetics Ltd
Mixis Genetics Ltd Pharmaceuticals: OtherHealth Technology Part of Teva Pharmaceutical Industries Ltd., Mixis Genetics Ltd is a French company that develops medicinal chemicals and botanical products. The company is based in Paris, France. The CEO of the company is Gilles Amsallem. Mixis Genetics was acquired by PLIVA dd, part of Teva Pharmaceutical Industries Ltd. from October 24, 2006 on April 01, 1999 for $3.26 million. | Corporate Officer/Principal | - |
PLIVA dd
PLIVA dd Pharmaceuticals: MajorHealth Technology PLIVA d.d. is a joint stock company incorporated and domiciled in the Republic of Croatia. The registered office is at Vukovarska 49, Zagreb. The Company is the parent of the PLIVA Group (“the Group”). The Group manufactures and supplies a wide range of pharmaceutical products as its core business. Non-core businesses consist of the manufacture and supply of DDDI products (diagnostics, disinfectants, dialysis, and infusions). | Corporate Officer/Principal | - |
EUCODIS Bioscience GmbH
EUCODIS Bioscience GmbH Drugstore ChainsRetail Trade EUCODIS Bioscience GmbH provides enzyme solutions. Its applications are used in biopharma, chemicals and cosmetics industries. The company is headquartered in Vienna, Austria. | Oprichter | - |
Opleiding van Wolfgang Schoenfeld
RWTH Aachen University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BAYER AG | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
PLIVA dd
PLIVA dd Pharmaceuticals: MajorHealth Technology PLIVA d.d. is a joint stock company incorporated and domiciled in the Republic of Croatia. The registered office is at Vukovarska 49, Zagreb. The Company is the parent of the PLIVA Group (“the Group”). The Group manufactures and supplies a wide range of pharmaceutical products as its core business. Non-core businesses consist of the manufacture and supply of DDDI products (diagnostics, disinfectants, dialysis, and infusions). | Health Technology |
Mixis Genetics Ltd
Mixis Genetics Ltd Pharmaceuticals: OtherHealth Technology Part of Teva Pharmaceutical Industries Ltd., Mixis Genetics Ltd is a French company that develops medicinal chemicals and botanical products. The company is based in Paris, France. The CEO of the company is Gilles Amsallem. Mixis Genetics was acquired by PLIVA dd, part of Teva Pharmaceutical Industries Ltd. from October 24, 2006 on April 01, 1999 for $3.26 million. | Health Technology |
EUCODIS Bioscience GmbH
EUCODIS Bioscience GmbH Drugstore ChainsRetail Trade EUCODIS Bioscience GmbH provides enzyme solutions. Its applications are used in biopharma, chemicals and cosmetics industries. The company is headquartered in Vienna, Austria. | Retail Trade |
EUCODIS Bioscience GmbH Deutschland
EUCODIS Bioscience GmbH Deutschland Miscellaneous Commercial ServicesCommercial Services EUCODIS GmbH researches and develops products for life science applications. It develops products for life science applications by utilizing vivo recombination and somatic hypermutation technology. The company focuses on development of products such as industrial enzymes, therapeutic proteins, agrochemicals, seed technologies, transgenic animals, biosynthetic pathways and human antibodies. The company was founded in 2004 and is headquartered in Vienna, Austria. | Commercial Services |